Apimeds Pharmaceuticals US (APUS) EPS (Weighted Average and Diluted) (2024 - 2025)

Apimeds Pharmaceuticals US (APUS) reported EPS (Weighted Average and Diluted) of -$0.08 for Q4 2025, down 100.0% on a YoY basis from $30024.0 billion in Q4 2024, and up 42.86% quarter-over-quarter from -$0.14 in Q3 2025.

Apimeds Pharmaceuticals US (APUS) EPS (Weighted Average and Diluted) (2024 - 2025) Analysis & Trends

Apimeds Pharmaceuticals US has reported EPS (Weighted Average and Diluted) for 2 years, with the latest figure at -$0.08 in Q4 2025.

  • For the quarter ending Q4 2025, EPS (Weighted Average and Diluted) fell 100.0% year-over-year to -$0.08; the trailing twelve-month figure through Dec 2025 stood at -$0.53 (down 194.44% YoY), and the FY2025 full-year result was -$0.55, down 205.56% from the prior year.
  • EPS (Weighted Average and Diluted) for Q4 2025 stood at -$0.08, up from -$0.14 in the prior quarter.
  • The five-year high for EPS (Weighted Average and Diluted) was -$0.04 in Q4 2024, with the low at -$0.26 in Q2 2025.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Weighted Avg. Diluted) (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 0.31
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 1.42
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 5.82
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 0.02
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 1.91
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 0.11
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -0.40
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -0.40
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 1.80
10 Apimeds Pharmaceuticals US 13.93 Mn 10.29 Mn - -0.08

Historic Data

Download Data
DateValue
Dec 31, 2025 -0.08
Sep 30, 2025 -0.14
Jun 30, 2025 -0.26
Mar 31, 2025 -0.05
Dec 31, 2024 -0.04
Sep 30, 2024 -0.04
Jun 30, 2024 -0.06
Mar 31, 2024 -0.04